Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The Peptide Landscape Is Shifting: What Secretary Kennedy's Joe Rogan Interview Could Mean for the Compounding Industry Frier Levitt FDA Peptide Regulation May Shift: What RFK Jr.'s Announcement Means for Compounding FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT Excellent news for us on the frontiers of medicine. Bringing back peptides to compounding pharmacies is the long awaited expectation from this administration. I voted for this. In September 2023, the Biden FDA Peptide Update: Category 2 Removals Explained